Remove 2018 Remove Diagnose Remove Healthcare Professional Remove Patients
article thumbnail

Leveraging U=U Interventions for Black Women With HIV

Physician's Weekly

The systematic review of peer-reviewed intervention was published from 2018 to 2023. The Southern US accounts for more than half of all new HIV diagnoses, and in Georgia, where I practice, new HIV diagnosis rates in 2022 were seven times higher among Black women than White women and two times higher than among White men.

article thumbnail

Time to stop driving? Podcast with Emmy Betz and Terri Cassidy

GeriPal

Eric: For those of you don’t know, Emmy was on our podcast back in 2018 … man, pre-COVID times. Initially, it was just because there weren’t really answers for my patients. We’re going to go into how to talk to patients about this, because Emmy, you’ve done some research on it. Eric: Yeah.

Family 102
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to Make an Alzheimer’s Diagnosis in Primary Care: A Podcast with Nathaniel Chin

GeriPal

So, the question becomes, what, if anything, should we do differently in the primary care setting to diagnose the disease? We address the following questions with Nate: Has anything changed for the primary care doctor when diagnosing Alzheimers? And when I asked the patient, well, what happened, the test was sprung on them.

article thumbnail

GeriPal Takeover! Nancy Lundeberg and Annie Medina-Walpole

GeriPal

We covered: The first parody song I wrote, for AGS 2018 in Orlando , about this article by Nancy Schoenborn on how to discuss stopping cancer screening. Alex joined in 2018. This was 2018 in AGS Orlando, and they did a song about when to stop screening for cancer for colon cancer. Alex 05:15 Oh, really? And so we did this song.

IT 65
article thumbnail

Amyloid Antibodies and the Role of the Geriatrician: Nate Chin, Sharon Brangman, and Jason Karlawish

GeriPal

However, as noted in our editorial published with the donanemab trial , the modest benefits of amyloid antibodies would likely not be questioned by patients, clinicians, or payers if amyloid antibodies were low risk, inexpensive, and simple to administer. The patients continued to be followed. However, they are none of these.

article thumbnail

Images of the Dying: A Podcast with Wendy MacNaughton, Lingsheng Li, and Frank Ostaseski

GeriPal

Alex 00:08 UCSF’s Division of Palliative Medicine are looking to build on their research and clinical programs and are interviewing candidates for the associate chief of research position and for full time physician faculty to join them in the in-patient and out-patient settings. Frank, welcome to the GeriPal podcast.

IT 123
article thumbnail

Pragmatic Trial of ACP: Jennifer Wolff, Sydney Dy, Danny Scerpella, and Jasmine Santoyo-Olsson

GeriPal

Only 5% of intervention patients received the facilitator-led component of the intervention (there were other components, facilitator-led was the most engaged component). I’m hearing dementia patients or patients with dementia. Eric 09:15 And then who were the patients just with dementia or were they. Is that right?